Mocanu E V, Cottell E, Waite K, Hennelly B, Collins C, Harrison R F
Human Assisted Reproduction Ireland, Rotunda Hospital, Dublin.
Ir Med J. 2008 Jun;101(6):181-4.
Cryopreservation of zygotes and subsequent thaw and transfer is an established ART treatment. We assessed if success rates frozen-thawed (day 2) zygotes are comparable with the outcome in fresh cycles of treatment. We performed a prospective follow-up and analysis of all frozen (FZT) and fresh cycles of treatment during a 12 months period. One hundred and nineteen patients in the frozen-thawed and 652 in the fresh group had a transfer. The overall thaw-survival rate was 71.7%. Clinical pregnancy rates per thaw and transfer were respectively 15.1% and 21% in the frozen and 29.1% (per transfer) in the fresh group. Implantation rates in fresh and frozen cycles were 16% and 12.3% respectively. The pregnancy loss rate was higher in the FZT group (29% vs. 18.3%). Cryopreservation of good quality zygotes, after fresh transfer offers optimal success rates in subsequent frozen treatment. It also encourages consideration of elective single zygote transfers.
受精卵的冷冻保存以及随后的解冻和移植是一种成熟的辅助生殖技术(ART)治疗方法。我们评估了冷冻-解冻(第2天)受精卵的成功率是否与新鲜周期治疗的结果相当。我们对12个月期间所有冷冻(冻融周期,FZT)和新鲜周期的治疗进行了前瞻性随访和分析。冻融周期组有119例患者进行了移植,新鲜周期组有652例。总体解冻存活率为71.7%。冷冻组每次解冻和移植的临床妊娠率分别为15.1%和21%,新鲜组(每次移植)为29.1%。新鲜周期和冷冻周期的着床率分别为16%和12.3%。冻融周期组的妊娠丢失率更高(29%对18.3%)。优质受精卵在新鲜移植后进行冷冻保存,在随后的冷冻治疗中可提供最佳成功率。这也促使人们考虑选择性单受精卵移植。